Publications
161. Mukherjea, D., Jajoo, S., Whitworth, C., Bunch, J.R., Turner, J.G., Rybak, L.P. and Ramkumar, V.: Short Interfering RNA Against Transient Receptor Potential Vanilloid-1 Attenuates Cisplatin-Induced Hearing Loss in the Rat. J Neurosci 28:13056-13065, 2008.
162. Rybak, LP, Mukherjea, D, Jajoo, S. Ramkumar, V.: Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies. Tohoku J Exp Med 219,177-186, 2009.
163. Jajoo, S, Mukherjea, D, Kumar, S, Sheth, S, Kaur, T, Rybak, L and Ramkumar, V.Role of β-Arrestin1/ERK MAP Kinase Pathway in Regulating Adenosine A1 Receptor Desensitization and Recovery. Am J Physiol Cell Physiol 298:C56-65, 2010.
164. Mukherjea D., Jajoo, S., Kaur, T.,Sheehan, K.E., Ramkumar, V. and Rybak, L.P.:Transtympanic administration of Short Interfering (si)RNA Against Cochlear Specific NADPH Oxidase isoform NOX3 Abrogates Cisplatin-Induced Hearing Loss in the Rat. Antioxidants & Redox Signaling. 2010, 13: 589-598
165. Mukherjea D, Jajoo S, Sheehan K, Kaur T, Sheth S, Bunch J, Perro C, Rybak LP, Ramkumar V. NOX3 NADPH Oxidase Couples Transient Receptor Potential Vanilloid 1 to STAT1-Mediated Inflammation and Hearing Loss. Antioxidants & Redox Signaling 14: 999-1010, 2011.
166. Mukherjea D, Jajoo S, Sheehan K, Kaur T, Sheth S, Ramkumar V, Rybak LP. The Design and Screening of Drugs for Acquired Sensorineural Hearing Loss. Exp Opinion Drug Discov (invited review, peer-reviewed) (in press).
167. Mukherjea D, Rybak LP. The Pharmacogenomics of Cisplatin-Induced Ototoxicity. Pharmacogenomics (peer-reviewed invited review) (in press).
168. Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V. Short Interfering RNA Against STAT1 Attenuates Cisplatin Induced Ototoxicity in the Rat by Suppressing Inflammation. Cell Death Dis (in press)(accepted June 3, 2011).
(These are the most recent of 168 publications)